A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors

Journal for ImmunoTherapy of Cancer(2015)

引用 4|浏览10
暂无评分
关键词
Liver Tumor, Maximum Tolerate Dose, Compute Tomography Guidance, Dose Cohort, Metastatic Liver Tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要